PMDA — authorised 14 January 2020
- Marketing authorisation holder: MSD K.K.
- Status: approved
PMDA authorised Pifeltro on 14 January 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 14 January 2020.
MSD K.K. holds the Japanese marketing authorisation.